Revenue: The sum of all revenue fields included for a company's operating activities.
Vertex Pharmaceuticals Incorporated (VRTX) had Revenue of $3.44B for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
|
Revenue |
$3.44B |
$653.60M |
|
$526.10M |
|
$2.91B |
|
$2.73B |
|
$712.90M |
|
$70.50M |
|
$783.40M |
|
$783.40M |
|
$653.60M |
|
$653.60M |
|
$653.60M |
|
$653.60M |
|
$712.90M |
|
$782.10M |
|
253.50M |
|
255.20M |
|
$2.58 |
|
$2.56 |
|
| Balance Sheet Financials | |
$11.69B |
|
$1.71B |
|
$21.05B |
|
$32.74B |
|
$5.00B |
|
$3.50B |
|
$6.83B |
|
$11.83B |
|
$20.91B |
|
$9.97B |
|
$20.91B |
|
253.52M |
|
| Cash Flow Statement Financials | |
$3.20B |
|
$-6.58B |
|
$3.33B |
|
$5.09B |
|
$4.99B |
|
$-99.20M |
|
$511.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.34 |
|
-- |
|
-- |
|
0.14 |
|
0.22 |
|
84.71% |
|
20.72% |
|
20.72% |
|
-- |
|
22.77% |
|
19.00% |
|
$2.85B |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.23 |
|
1.49 |
|
60.45 |
|
3.13% |
|
6.56% |
|
2.00% |
|
2.68% |
|
$82.47 |
|
$11.18 |
|
$12.53 |
|